Evidence map›Paper›PMID 42196996›Full record

ArticleNutrients2026

Enhancing Quercetin Bioavailability Attenuates Aging Phenotypes via the Gut Microbiota-Intestinal Barrier Axis in Aged Mice.

Yuji Naito, Katsura Mizushima, Ryo Inoue, Tomohisa Takagi

Abstract read
In one paragraph

Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuji NaitoDepartment of Human Immunology and Nutrition Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan.ORCID 0000-0001-5443-788X
Katsura MizushimaDepartment of Human Immunology and Nutrition Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan.
Ryo InoueLaboratory of Animal Science, Department of Applied Biological Sciences, Faculty of Agriculture, Setsunan University, Osaka 573-0101, Japan.ORCID 0000-0002-7233-366X
Tomohisa TakagiMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan.ORCID 0000-0002-6119-4828

Funding

COI-NEXT, JST JPMJPF2210 and JPMJPF2403Ministry of Agriculture, Forestry and Fisheries JPJ009842
6 · The paper itself

Abstract

BACKGROUND/

objectivesAging is characterized by progressive functional decline associated with alterations in gut microbiota, epithelial barrier dysfunction, and cellular senescence. Although quercetin has been proposed as a potential anti-aging compound, its clinical application is limited by poor bioavailability. In this study, we investigated whether enhancing quercetin bioavailability using EubioQuercetin (EQN) modulates aging-related phenotypes through the gut microbiota-intestinal barrier axis.

methodsMale C57BL/6J mice were treated with EQN or conventional quercetin (CQN) for 12 weeks. External aging phenotypes were assessed using a composite aging score based on hair glossiness, hair loss, and the presence of white hair. Gut microbiota composition was analyzed via 16S rRNA sequencing with centered log-ratio transformation, and intestinal gene expression was assessed by quantitative reverse transcription-polymerase chain reaction.

resultsEQN significantly reduced the aging score compared with the control group (median 4.5 vs. 8,

conclusionsThese findings indicate that enhancing quercetin bioavailability attenuates externally assessed aging phenotypes in aged mice and is associated with coordinated changes in gut microbiota and intestinal gene expression. Modulation of the gut microbiota-intestinal barrier axis may represent a potential mechanism underlying these effects.

Indexed as

AgingGastrointestinal MicrobiomeIntestinal MucosaQuercetinAnimalsBiological AvailabilityIntestinal Barrier FunctionMaleMiceMice, Inbred C57BLPhenotypeRNA, Ribosomal, 16SQuercetinRNA, Ribosomal, 16Sagingbioavailabilitygut microbiotaquercetinsenescence

Identifiers

PMID42196996
PMCPMC13210256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.